ArticleAddiction & health2025
Sociodemographic and Toxico-clinical Characteristics of Patients with Opioid/Stimulant Poisoning.
Article in Addiction & health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to examine the toxico-clinical and sociodemographic characteristics of patients who have experienced poisoning from common illicit drugs, such as opioids and stimulants. Methods: This retrospective chart review study was conducted on cases of opioid and stimulant poisoning who were admitted to the referral poisoning emergency center in the central part of Iran, Isfahan, from January 2019 to January 2020. The toxico-clinical and sociodemographic characteristics of patients were evaluated. Findings: Data obtained from 496 patients were analyzed. Poisoning with opioids and stimulants accounted for 67.13% and 7.86% of cases, respectively. Most of the patients in both the opioid and stimulant groups were male. The most common route of poisoning was ingestion (82%) for opioids and inhalation (43.6%) for stimulants. Suicide (40.2%) was common in patients with opioid poisoning, whereas abuse (28.2%) was more commonly observed in stimulant poisoning. There were no significant differences regarding marital status, occupation, education, criminal convictions, history of somatic diseases, and psychiatric diseases between patients with opioid and stimulant poisoning. The mortality rate in opioid poisoning was 0.9%, whereas no deaths were reported in patients with stimulant poisoning. Binary regression analysis showed that age, coma/stupor, abnormal respiratory manifestations, previous cardiovascular disease, incomplete response to naloxone, and endotracheal intubation were predictive factors for worse outcomes (complications/death) in opioid poisoning. Conclusion: Opioid poisoning was more common than stimulant poisoning. Except for the type and route of exposure, there were no significant differences between patients poisoned with opioid or stimulant drugs. This highlights the necessity for targeted interventions based on specific clinical characteristics to improve patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.